Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.00001
-0.00009 (-90.00%)
At close: Aug 4, 2026
Iterum Therapeutics Revenue
Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.
Revenue (ttm)
390.00K
Revenue Growth
n/a
P/S Ratio
0.00
Revenue / Employee
43.33K
Employees
9
Market Cap
528.00
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nabriva Therapeutics | 29.56M |
| Predictive Technology Group | 19.17M |
| Alzex Neuropharma | 4.73M |
| Biora Therapeutics | 892.00K |
| Proteonomix | 26.00K |
Iterum Therapeutics News
- 4 months ago - Iterum files wind-up petition due to limited cash, inability to raise equity - Reuters
- 4 months ago - Iterum Therapeutics Announces Filing of Winding Up Petition - GlobeNewsWire
- 6 months ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 6 months ago - Iterum Therapeutics Proxy statement: Proxy Filing - Filings
- 6 months ago - Iterum Therapeutics Proxy statement: Proxy Filing - Filings
- 7 months ago - Iterum Therapeutics Slides: Investor presentation - Filings
- 7 months ago - Iterum Therapeutics Proxy statement: Proxy Filing - Filings
- 8 months ago - Iterum Therapeutics Proxy statement: Proxy Filing - Filings